Suppr超能文献

改善门诊环境中的用药核对工作。

Improving medication reconciliation in the outpatient setting.

作者信息

Varkey Prathibha, Cunningham Julie, Bisping D Susan

机构信息

Division of Preventive and Occupational Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

出版信息

Jt Comm J Qual Patient Saf. 2007 May;33(5):286-92. doi: 10.1016/s1553-7250(07)33033-x.

Abstract

BACKGROUND

A systematic study into outpatient medication reconciliation was conducted to determine if a multifaceted intervention influencing providers and patients reduced discrepancies related to inadequate prescription medication reconciliation in an outpatient setting.

METHODS

A prospective trial was conducted on 104 primary care patients at the Mayo Clinic. Patients in Phase I received standard care. Patients in Phase II received the intervention reconciliation process, which consisted of (1) mailed letters before appointments to remind patients to bring medication bottles or updated medication lists to their visits, (2) verification, and (3) correction of the medication list in the electronic medical record by the patient, and academic detailing and weekly audit and feedback of performance.

RESULTS

Interventions resulted in a decrease in prescription medication errors from 88.9% of the visits in Phase 1 to 66% of the visits in Phase II (p = .005) and from 98.2% of the visits in Phase I to 84% of the visits in Phase II (p = .0134) when all medications were considered. The average number of discrepancies per patient decreased by more than 50% from 5.24 in Phase I to 2.46 in Phase II. The majority of discrepancies were minor.

DISCUSSION

A multifaceted intervention including various members of the health care provider team (and the patient) is crucial to enhancing medication reconciliation.

摘要

背景

开展了一项关于门诊用药核对的系统研究,以确定一项影响医护人员和患者的多方面干预措施是否能减少门诊环境中与处方用药核对不足相关的差异。

方法

在梅奥诊所对104名初级保健患者进行了一项前瞻性试验。第一阶段的患者接受标准护理。第二阶段的患者接受干预核对流程,该流程包括:(1)预约前邮寄信件,提醒患者就诊时携带药瓶或更新后的用药清单;(2)核实;(3)患者在电子病历中校正用药清单,以及学术详述和每周的绩效审核与反馈。

结果

当考虑所有药物时,干预措施使处方用药错误率从第一阶段就诊次数的88.9%降至第二阶段就诊次数的66%(p = 0.005),从第一阶段就诊次数的98.2%降至第二阶段就诊次数的84%(p = 0.0134)。每位患者的差异平均数从第一阶段的5.24大幅下降至第二阶段的2.46,降幅超过50%。大多数差异较小。

讨论

包括医疗保健提供团队(以及患者)的不同成员在内的多方面干预措施对于加强用药核对至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验